State Street’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-240,454
| Closed | -$5.55M | – | 4014 |
|
|
2020
Q4 | $5.55M | Sell |
240,454
-12,316
| -5% | -$284K | ﹤0.01% | 2912 |
|
|
2020
Q3 | $2.57M | Buy |
252,770
+7,661
| +3% | +$78K | ﹤0.01% | 3095 |
|
|
2020
Q2 | $3.65M | Buy |
245,109
+35,594
| +17% | +$530K | ﹤0.01% | 2920 |
|
|
2020
Q1 | $2.55M | Buy |
209,515
+104,629
| +100% | +$1.28M | ﹤0.01% | 2948 |
|
|
2019
Q4 | $1.66M | Buy |
104,886
+42,767
| +69% | +$677K | ﹤0.01% | 3306 |
|
|
2019
Q3 | $763K | Buy |
+62,119
| New | +$763K | ﹤0.01% | 3452 |
|